1st Circ. Backs GSK's Preemption Win Against Zofran MDL
The First Circuit affirmed on Monday GlaxoSmithKline's summary judgment win against hundreds of product liability lawsuits in multidistrict litigation alleging GSK failed to warn consumers that the anti-nausea drug Zofran might...To view the full article, register now.
Already a subscriber? Click here to view full article